POSTS

19 posts (2 pages)
Anthropic Spends $400M to Acquire Biotech AI Startup: Claude Formally Enters Drug Discovery

Anthropic Spends $400M to Acquire Biotech AI Startup: Claude Formally Enters Drug Discovery

April 5, 2026

Anthropic announces a $400M stock acquisition of stealth-mode biotech AI company Coefficient Bio. Founded by former Genentech Prespective Design team members, the startup focuses on AI-accelerated …

Read more
Cognichip Uses AI to Design AI Chips: $60M Raised, Aims to Cut Development Costs by 75%

Cognichip Uses AI to Design AI Chips: $60M Raised, Aims to Cut Development Costs by 75%

April 3, 2026

A startup is using deep learning models to redesign chip development workflows, targeting a 50% reduction in concept-to-production time.

Read more
OpenAI's $122 Billion Mega Round: $852B Valuation, IPO Confirmed

OpenAI's $122 Billion Mega Round: $852B Valuation, IPO Confirmed

April 2, 2026

OpenAI completes the largest private funding round in history. SoftBank leads the $122B raise at a $852B valuation, IPO confirmed.

Read more
OpenAI Unveils GPT-5: Dramatically Enhanced Reasoning, Multimodal AI Era Officially Arrives

OpenAI Unveils GPT-5: Dramatically Enhanced Reasoning, Multimodal AI Era Officially Arrives

April 1, 2026

OpenAI officially releases GPT-5 with dramatically improved logical reasoning capabilities. The multimodal AI era is here.

Read more
Workspace Efficiency Revolution: Google Gemini 2.5 Deep Integration Analysis

Workspace Efficiency Revolution: Google Gemini 2.5 Deep Integration Analysis

March 31, 2026

Google officially integrates Gemini 2.5 deeply into Workspace. We break down what it means for enterprise productivity.

Read more
The Olympics of Open Source: Llama 4 Arrives, 70B Parameters Challenge Closed-Model Ceiling

The Olympics of Open Source: Llama 4 Arrives, 70B Parameters Challenge Closed-Model Ceiling

March 30, 2026

Meta officially releases the Llama 4 model series, with the 70B parameter model directly challenging the performance ceiling of closed-source alternatives.

Read more
A Giant Leap for Medicine: AI Reduces Drug Development Cycle from Years to Months

A Giant Leap for Medicine: AI Reduces Drug Development Cycle from Years to Months

March 29, 2026

A biotech company leverages AI-driven drug discovery platforms to dramatically compress development timelines from years to months.

Read more
The Final Piece of the AI Puzzle: NVIDIA B200 Enters Mass Production, Inference Costs Set to Plummet

The Final Piece of the AI Puzzle: NVIDIA B200 Enters Mass Production, Inference Costs Set to Plummet

March 28, 2026

NVIDIA announces next-generation AI chips entering mass production, optimized for large language model inference, promising dramatic cost reductions.

Read more
EU AI Act Enforcement Begins: Compliance Becomes Corporate Survival Line

EU AI Act Enforcement Begins: Compliance Becomes Corporate Survival Line

March 27, 2026

The EU AI Act is now in full effect. All high-risk AI systems deployed in the EU must pass compliance reviews, with fines reaching up to 7% of global revenue.

Read more